Holen Sie sich die Stockscreener-App
54.86
4.02%
2.12
Crispr Therapeutics Ag Aktie (CRSP) Neueste Nachrichten
Baker BROS. Advisors LP Has $22.26 Million Position in CRISPR Therapeutics AG $CRSP - MarketBeat
Visual trend scoring systems applied to CRISPR Therapeutics AG2025 Trading Recap & Fast Exit and Entry Strategy Plans - Newser
With 79% Ownership in CRISPR Therapeutics AG (NASDAQ:CRSP), Institutional Investors Have a Lot Riding on the Business - 富途牛牛
How sentiment analysis helps forecast CRISPR Therapeutics AG - Newser
Invesco Ltd. Cuts Position in CRISPR Therapeutics AG $CRSP - MarketBeat
Does CRISPR Therapeutics AG have pricing powerJuly 2025 Outlook & Risk Managed Investment Strategies - خودرو بانک
Will CRISPR Therapeutics AG benefit from geopolitical trendsPortfolio Performance Report & High Accuracy Swing Entry Alerts - خودرو بانک
Will CRISPR Therapeutics AG stock hit new highs in YEARPortfolio Update Report & Technical Confirmation Trade Alerts - خودرو بانک
Will CRISPR Therapeutics AG benefit from current market trendsJuly 2025 Macro Moves & Long-Term Growth Plans - خودرو بانک
Is CRISPR Therapeutics AG a speculative investment2025 Bull vs Bear & Free Community Consensus Stock Picks - خودرو بانک
Can machine learning forecast CRISPR Therapeutics AG recovery2025 EndofYear Setup & Safe Capital Investment Plans - Newser
Will earnings trigger a reversal in CRISPR Therapeutics AGJuly 2025 Earnings & Long-Term Safe Return Strategies - Newser
Identifying reversal signals in CRISPR Therapeutics AG2025 Dividend Review & Short-Term High Return Ideas - Newser
How hedge fund analytics apply to CRISPR Therapeutics AG stockPortfolio Performance Summary & Capital Protection Trading Alerts - Newser
Will CRISPR Therapeutics AG stock recover after recent dropQuarterly Profit Summary & Weekly High Conviction Ideas - Newser
Zacks Research Has Optimistic Outlook of CRSP Q1 Earnings - MarketBeat
CRISPR Therapeutics AG (NASDAQ:CRSP) Receives $71.60 Consensus Price Target from Analysts - MarketBeat
Will breakout in CRISPR Therapeutics AG lead to full recoveryQuarterly Profit Summary & High Accuracy Swing Trade Signals - Newser
Orbis Allan Gray Ltd Buys 86,813 Shares of CRISPR Therapeutics AG $CRSP - MarketBeat
Real time pattern detection on CRISPR Therapeutics AG stockJuly 2025 PostEarnings & Reliable Price Breakout Alerts - Newser
Why This Biotech Company Could Be a Growth Stock Powerhouse - The Motley Fool
Bank of America Securities Sticks to Their Buy Rating for Crispr Therapeutics AG (CRSP) - The Globe and Mail
Forecasting CRISPR Therapeutics AG price range with options dataJuly 2025 Pullbacks & Daily Market Momentum Tracking - Newser
Sentiment analysis tools applied to CRISPR Therapeutics AG2025 EndofYear Setup & Weekly Market Pulse Alerts - Newser
Rafferty Asset Management LLC Trims Stock Holdings in CRISPR Therapeutics AG $CRSP - MarketBeat
Detecting support and resistance levels for CRISPR Therapeutics AGJuly 2025 WrapUp & Daily Volume Surge Signals - Newser
Multi asset correlation models including CRISPR Therapeutics AGJuly 2025 Earnings & Low Risk Entry Point Guides - Newser
Why is CRISPR Therapeutics AG stock going down2025 Earnings Surprises & Technical Analysis for Trade Confirmation - خودرو بانک
CRISPR Therapeutics Down 5.3% Since Last Earnings Report: Can It Rebound? - AInvest
CRISPR Therapeutics (CRSP) Down 5.3% Since Last Earnings Report: Can It Rebound? - Yahoo Finance
Using Bollinger Bands to evaluate CRISPR Therapeutics AGJuly 2025 Decliners & High Conviction Buy Zone Picks - Newser
Historical volatility pattern of CRISPR Therapeutics AG visualizedTrade Entry Report & High Conviction Trade Alerts - Newser
What machine learning models say about CRISPR Therapeutics AGQuarterly Profit Review & Real-Time Buy Signal Alerts - Newser
Should you wait for a breakout in CRISPR Therapeutics AG2025 Retail Activity & High Return Stock Watch Alerts - Newser
Can technical indicators confirm CRISPR Therapeutics AG’s reversalTrade Performance Summary & Free Low Drawdown Momentum Trade Ideas - Newser
CRISPR Therapeutics (NASDAQ:CRSP) Stock Rating Upgraded by Zacks Research - MarketBeat
Is it too late to sell CRISPR Therapeutics AGJuly 2025 Retail & Verified Chart Pattern Trade Signals - Newser
Does CRISPR Therapeutics AG have declining or rising EPSWeekly Market Report & Technical Entry and Exit Alerts - خودرو بانک
Can trapped investors hope for a rebound in CRISPR Therapeutics AGWatch List & Verified Momentum Stock Alerts - Newser
Risk Analysis: Is CRISPR Therapeutics AG part of any major indexJuly 2025 Movers & Precise Entry and Exit Recommendations - خودرو بانک
When is the best time to exit CRISPR Therapeutics AGJuly 2025 Update & Safe Entry Point Alerts - Newser
Statistical indicators supporting CRISPR Therapeutics AG’s strength2025 Dividend Review & Community Shared Stock Ideas - Newser
Technical analysis overview for CRISPR Therapeutics AG stockPortfolio Profit Report & Technical Entry and Exit Alerts - Newser
1.40%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):